Jefferies
Zaki Molvi, PhD, currently serves as a Senior Associate in Biotech Equity Research at Jefferies, where the team has achieved a #1 ranking in the Institutional Investor (II) rankings for SMID biotech. Prior to this role, Zaki was the Director of Computational Biology & Bioinformatics at Omicify, focusing on developing custom bioinformatics pipelines for clients within the biotech and pharmaceutical sectors. Zaki also pursued a PhD in Immunology & Pediatrics at Memorial Sloan Kettering Cancer Center under Richard O'Reilly, and contributed to machine learning research at Weill Cornell Medicine. Zaki holds a Bachelor of Science in Chemical Engineering from UC Irvine and a Doctor of Philosophy in Physiology, Biophysics, and Systems Biology from Cornell University.
Jefferies
37 followers
Jefferies, the global investment banking firm, has served companies and investors for 60 years. Headquartered in New York, with offices in over 30 cities around the world, the firm provides clients with capital markets and financial advisory services, institutional brokerage and securities research, as well as asset and wealth management. The firm provides research and execution services in equity, fixed income, and foreign exchange markets, as well as a full range of investment banking services including underwriting, mergers and acquisitions, restructuring and recapitalization, and other advisory services, with all businesses operating in the Americas, Europe and Asia.